Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B Profit Margin

Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B posts a profit margin of 4.52% as of June 2026. That compares with 7.41% in the prior-year period — down 39.0% year over year. That is below the Healthcare sector average of 21.34%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B's profit margin was 7.41%. The latest reading is 4.52% — a 39.0% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 21.34% is typical. Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B's 4.52% is lower that level. That is roughly 78.8% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 4.52% as of June 2026; use YoY and peer views to separate noise from signal.

Context for BDXB's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 21.34%), and (3) consistency with growth and profitability. This page covers the first two; Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B's other metric pages and overview cover the third.